Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

SHA:600223 Revenue

Lushang Freda Pharmaceutical had revenue of 1.01B CNY in the quarter ending June 30, 2026, with 10.44% growth. This brings the company's total for the last twelve months to 3.77B, down -1.98% year-over-year. In the year 2025, Lushang Freda Pharmaceutical had annual revenue of 3.65B, down -8.33%. That makes Lushang Freda Pharmaceutical the 10,552nd largest company in the world by revenue and 1,730th in China.

• Revenue (ttm): 3.77B
• Revenue Growth: -1.98%
• P/S Ratio: 1.47
• Revenue / Employee: 1.07M
• Employees: 3,514
• Market Cap: 5.59B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical and Chemical Industry 3.08B 84.2%
• Property Management and Other Industries 579.93M 15.8%

Fiscal year ended Dec 31, 2025 See the full SHA:600223 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.65B	-331.68M	-8.33%
Dec 31, 2024	3.98B	-596.17M	-13.02%
Dec 31, 2023	4.58B	-8.37B	-64.65%
Dec 31, 2022	12.95B	588.17M	4.76%
Dec 31, 2021	12.36B	-1.25B	-9.20%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error